Patents by Inventor Mike E. Moore

Mike E. Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250049324
    Abstract: Near Infrared Spectroscopy is employed to non-invasively detect blood glucose concentrations, in a multi-sensing detection device. A multi-layered artificial neural network is used to assess these relationships of non-linear interference from human tissue, as well as differences among individuals, and accurately estimate blood glucose levels. Diffuse reflectance spectrum from the palm at six different wavelengths analyzed with a neural network, results in a correlation coefficient as high as 0.9216 when compared to a standard electrochemical glucose analysis test.
    Type: Application
    Filed: September 9, 2024
    Publication date: February 13, 2025
    Inventors: Bruce Matichuk, Mike E. Moore
  • Publication number: 20230355145
    Abstract: Near Infrared Spectroscopy (NIS) is employed to non-invasively detect health-related conditions, such as blood glucose concentrations, and accounting for non-linear interference from human tissues, the differences among individuals, and multiple interfering compounds within blood. A multi-layered artificial neural network can be used to assess these relationships and accurately estimate blood glucose levels. Diffuse reflectance spectrum at six different wavelengths are analyzed with a neural network, resulting in a correlation coefficient as high as 0.9216 when compared to a standard electrochemical glucose analysis test.
    Type: Application
    Filed: May 9, 2023
    Publication date: November 9, 2023
    Inventors: Bruce Matichuk, Mike E. Moore
  • Publication number: 20230284905
    Abstract: Near Infrared Spectroscopy is employed to non-invasively detect blood glucose concentrations, in a multi-sensing detection device. A multi-layered artificial neural network is used to assess these relationships of non-linear interference from human tissue, as well as differences among individuals, and accurately estimate blood glucose levels. Diffuse reflectance spectrum from the palm at six different wavelengths analyzed with a neural network, results in a correlation coefficient as high as 0.9216 when compared to a standard electrochemical glucose analysis test.
    Type: Application
    Filed: March 6, 2023
    Publication date: September 14, 2023
    Inventors: Bruce Matichuk, Mike E. Moore